Semaglutide Peptide (GLP1-S)

Price range: $95.00 through $215.00

🧬 Semaglutide Peptide (GLP1-S) – Long-Acting GLP-1 Receptor Agonist for Metabolic Research
A synthetic 31-amino acid peptide analog of human GLP-1. Features C18 fatty diacid chain for extended half-life. Extensively studied for appetite regulation, glycemic control, and cardiovascular and metabolic outcomes. High purity (≥99%). For lab use only. ⚡

⚠️ Note: Product image is illustrative only and may not represent the actual item. Refer to description for accurate details on purity, quantity & packaging.
84 People watching this product now!
SKU: N/A Category:
Description

Welcome to Buy Peptides Online USA, your premier domestic source for high-purity research peptides designed for serious scientific investigations. This product is intended strictly for laboratory research use only and is not for human or veterinary consumption. It is not a medicine, drug, or medical device and has not been evaluated by the FDA.

A Breakthrough in GLP-1 Research: An Introduction to Semaglutide Peptide 🔬

For researchers focused on the frontiers of metabolic disease, obesity, and cardiovascular health, Semaglutide stands as one of the most significant and extensively studied peptide molecules of the 21st century. This synthetic 31-amino acid peptide is a long-acting analog of the endogenous incretin hormone glucagon-like peptide-1 (GLP-1) , engineered with strategic modifications to resist rapid degradation and extend its circulating half-life .

Semaglutide's significance in research has expanded dramatically since its initial development. What distinguishes it from earlier GLP-1 analogs is its remarkable pharmacokinetic profile, achieved through two key structural modifications: substitution of the amino acid at position 8 (alanine to alpha-aminoisobutyric acid) to protect against DPP-4 cleavage, and attachment of a C18 fatty diacid chain at position 18 to facilitate strong, reversible albumin binding . These modifications result in a plasma half-life of approximately one week, making it suitable for once-weekly administration in research models.

Beyond its well-established role in glycemic control, semaglutide has demonstrated profound effects on body weight, cardiovascular outcomes, and inflammation. A landmark 2021 trial published in the New England Journal of Medicine reported that once-weekly subcutaneous semaglutide (2.4 mg) produced a mean weight reduction of 14.9% in individuals with obesity . Subsequent research has explored its benefits across a broad spectrum of conditions, from knee osteoarthritis and metabolic liver disease to heart failure and sleep apnea, cementing its position as a cornerstone tool in metabolic research.

What is Semaglutide Peptide?

Semaglutide is a synthetic 31-amino acid peptide with the sequence H-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH, featuring a C18 diacid (octadecanedioyl) conjugated to a glutamic acid linker on the lysine residue at position 20 . Its molecular formula is C₁₈₇H₂₉₁N₄₅O₅₉ with a molecular weight of approximately 4113.6 Da . It is identified by CAS number 910463-68-2 .

Its primary mechanisms of action, established through extensive research, include:

  1. GLP-1 Receptor Activation: Semaglutide is a potent and selective agonist of the GLP-1 receptor, a G protein-coupled receptor (GPCR) expressed in pancreatic islets, the gastrointestinal tract, the brain, the cardiovascular system, and other tissues .
  2. Regulation of Appetite and Food Intake: By activating GLP-1 receptors in the hypothalamus and brainstem, semaglutide reduces appetite, increases satiety, and decreases food intake, leading to substantial and sustained weight loss .
  3. Glucose-Dependent Insulin Secretion: In the presence of elevated glucose, semaglutide stimulates insulin secretion from pancreatic beta-cells while simultaneously suppressing glucagon release, improving glycemic control .
  4. Anti-Inflammatory and Cardiovascular Effects: Beyond its metabolic actions, semaglutide has demonstrated anti-inflammatory properties, reducing biomarkers of inflammation and improving cardiovascular outcomes, including reductions in major adverse cardiovascular events (MACE) .

🔬 Primary Research Focuses and Applications

The Semaglutide Peptide is at the forefront of multiple cutting-edge research areas, validated by numerous peer-reviewed studies:

  • Obesity and Weight Management Research: Semaglutide is a premier tool for studying pharmacological weight loss. The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program demonstrated mean weight reductions of 14.9% over 68 weeks with once-weekly 2.4 mg semaglutide in individuals with obesity . A 2024 study in Nature Medicine extended these findings, demonstrating the efficacy and safety of oral semaglutide (50 mg daily) in adolescents with obesity .

  • Knee Osteoarthritis (OA) and Musculoskeletal Research (2025): A very recent 2025 trial published in JAMA investigated semaglutide's effects in persons with obesity and knee osteoarthritis. The study found that once-weekly 2.4 mg semaglutide led to significantly greater reductions in body weight (mean difference -13.7%) and improvements in knee pain, as measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscore (mean difference -41.7 points) compared to placebo .

  • Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Research (2025): A 2025 study in the Journal of Hepatology examined semaglutide's effects on liver health in individuals with MASLD and obesity. The research demonstrated that semaglutide treatment was associated with significant reductions in liver enzyme levels (ALT, AST) and improvements in biomarkers of liver fibrosis .

  • Cardiovascular and Heart Failure Research: The SELECT trial (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity) reported that semaglutide (2.4 mg) reduced the incidence of major adverse cardiovascular events (MACE) by 20% in individuals with preexisting cardiovascular disease and overweight or obesity .

  • Inflammation and Biomarker Research: Semaglutide has been shown to reduce circulating levels of high-sensitivity C-reactive protein (hs-CRP), a key marker of inflammation, by approximately 40% in various patient populations, independent of weight loss .

🧪 Product Specifications & Technical Data

At Buy Peptides Online USA, we ensure your research is built on a foundation of quality and consistency. This peptide is manufactured to rigorous laboratory standards and verified through advanced analytical methods.

Specification Details
Peptide Semaglutide (GLP1-S)
Sequence H-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH (with C18 diacid on Lys20)
CAS Number 910463-68-2
Molecular Formula C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight ~4113.6 Da
Synonyms GLP-1 (7-37), NN9924, Ozempic®, Rybelsus®
Purity ≥99% (Verified via HPLC and Mass Spectrometry)
Quality Verification Third-party tested for identity and purity (HPLC, MS). Certificate of Analysis (COA) available .
Physical Appearance White to off-white lyophilized powder
Solubility Soluble in sterile water and other aqueous solutions .
Storage (Lyophilized) Store at -20°C (-4°F) or below, desiccated, protected from light and moisture. Stable for up to 3 years at -20°C .
Storage (Reconstituted) For short-term use (up to 1 week), store at 2-8°C. For long-term storage, aliquot and freeze at -80°C. Avoid repeated freeze-thaw cycles .
Intended Application Laboratory Research Use Only (RUO)

✅ Why Choose Buy Peptides Online USA for Your Research?

Sourcing reliable research compounds is critical for reproducible, high-impact science. Here is why discerning researchers across the USA trust us:

  • Verified Purity & Potency: We provide access to Certificates of Analysis (COA) and rely on advanced analytical methods like High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm the identity and purity (≥99%) of every batch . This commitment ensures the integrity of your experimental data.
  • Research-Focused Integrity: We strictly adhere to research-use-only (RUO) guidelines. Our product descriptions are factual, focusing on chemical properties and cited research applications, never unverified human-use claims. This product is not for diagnostic or therapeutic use .
  • Fast & Discreet USA Shipping: As a USA-based supplier, we offer fast, reliable shipping across the United States with discreet packaging to ensure your order arrives safely, professionally, and on time for your critical research timelines. Enjoy free shipping on orders over $300.
  • Expert Support & Authenticity Guarantee: Our team provides technical consultation to support your work. We stand behind the authenticity and quality of all our products, offering a product replacement service and clear complaint handling.

📝 Handling, Storage, & Important Safety Information

  • Critical Storage Information: Upon receipt, store the lyophilized powder at -20°C (-4°F) or below, desiccated, protected from light and moisture. It is stable for up to 3 years under these conditions . Although stable at room temperature for short periods (weeks), long-term storage requires freezing .
  • Handling for Research Use: This product is for laboratory use only by qualified professionals. Before opening, allow the vial to warm to room temperature and briefly centrifuge to concentrate material at the bottom. Reconstitute in sterile, ultra-pure water to achieve desired concentration. Gently invert to mix; do not vortex.
  • Stability Considerations: Once reconstituted, store at 2-8°C for short-term use (up to 1 week). For longer storage, aliquot and freeze at -80°C. Avoid repeated freeze-thaw cycles at all costs, as this can degrade the peptide and reduce its bioactivity .
  • Safety Considerations: Semaglutide is a potent, bioactive peptide for research use only. Its safety profile in long-term studies continues to be evaluated in ongoing clinical trials. Always wear appropriate personal protective equipment (PPE), including lab coats, safety glasses, and nitrile gloves. Work in a laminar flow hood or well-ventilated area.
  • Warning: This product is not for human or veterinary use. It is not a drug, food, or cosmetic. Not for human consumption or diagnostic use . For laboratory research only.

❓ Frequently Asked Questions (FAQs)

Q: What is the primary mechanism of action for Semaglutide?

A: Semaglutide is a long-acting GLP-1 receptor agonist that activates GLP-1 receptors in the pancreas, brain, and peripheral tissues. This leads to glucose-dependent insulin secretion, reduced appetite, and decreased food intake .

Q: What structural modifications give Semaglutide its long half-life?

A: Semaglutide features two key modifications: a substitution at position 8 (Aib) to resist DPP-4 degradation, and a C18 fatty diacid chain attached to lysine at position 20, which promotes strong, reversible binding to albumin, extending its half-life to approximately one week .

Q: What are the most recent research findings on Semaglutide (2024-2025)?

A: Recent groundbreaking studies have demonstrated:

  1. Adolescent Obesity (2024): Oral semaglutide (50 mg daily) was efficacious and safe in adolescents with obesity .
  2. Knee Osteoarthritis (2025): Semaglutide (2.4 mg weekly) significantly reduced body weight and improved knee pain in persons with obesity and knee OA .
  3. Metabolic Liver Disease (2025): Semaglutide treatment was associated with reductions in liver enzymes and biomarkers of fibrosis in individuals with MASLD .

Q: How does Semaglutide differ from other GLP-1 agonists?

A: Semaglutide's structural modifications result in a significantly longer half-life (∼1 week) than earlier GLP-1 agonists like exenatide. This allows for once-weekly dosing and more consistent receptor activation . It has also demonstrated superior weight loss efficacy in head-to-head trials .

Q: How do you verify the purity and identity of Semaglutide?

A: We ensure every batch is rigorously analyzed using High Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) . HPLC confirms a purity level of ≥99% , while Mass Spectrometry verifies the precise molecular weight (~4113.6 Da) , ensuring the correct peptide structure and identity. Certificates of Analysis (COA) are available upon request .

Q: What are the critical storage conditions for Semaglutide?

A: Store the lyophilized powder at -20°C (-4°F) or below, desiccated and protected from light and moisture . Once reconstituted, store at 2-8°C for short-term use (up to 1 week). For longer storage, aliquot and freeze at -80°C. Avoid repeated freeze-thaw cycles.

Q: Is Semaglutide approved for clinical use?

A: Yes, semaglutide is FDA-approved for type 2 diabetes (Ozempic®, Rybelsus®) and chronic weight management (Wegovy®). However, this product is sold strictly for laboratory research use only and is not intended for human consumption.

Q: Is Semaglutide prohibited in sports research?

A: Researchers should be aware that semaglutide, as a peptide hormone and metabolic modulator, would be considered a prohibited substance under the general category of peptide hormones and growth factors on the World Anti-Doping Agency (WADA) Prohibited List. It is intended for legitimate scientific research only.

Ready to Advance Your Research? 🚀

Equip your laboratory with a breakthrough GLP-1 receptor agonist for studying metabolic regulation, obesity, cardiovascular health, and inflammation. Order the high-purity Semaglutide Peptide (GLP1-S) today from Buy Peptides Online USA. Benefit from our fast USA shipping, secure payments (including crypto), and the confidence that comes from rigorously tested, research-grade compounds validated by the latest 2024-2025 discoveries. For any questions about this product or your order, our support team is here to provide technical consultation.

Additional information
Analysis Certificate

COA Available

Certifications

GMP Manufactured

,

Third-Party Tested

Intended Use

For Laboratory Use

,

Not for Human Consumption

,

Not for Diagnostic Use

,

Research Use Only (RUO)

Purity

≥98%

Shelf Life

12 months

Storage

Protect from Light

,

Refrigerate (2-8°C)

,

Store in a Cool, Dry Place

Form

Vials (Injectable, Often Lyophilized Powder or Solution)

Primary Function

Weight Loss

,

Weight Management

Functional Sub-Type

GLP-1 & GIP Receptor Agonist

Quantity

3mg

,

6mg

,

10mg